Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference
AUSTIN, Texas, May 31, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 clinical trials, announced that the Company will participate in the 2023 BIO International Convention held June 5-8, 2023 in Boston and the Jefferies Healthcare Conference held June 7-9, 2023 in New York City.
- AUSTIN, Texas, May 31, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 clinical trials, announced that the Company will participate in the 2023 BIO International Convention held June 5-8, 2023 in Boston and the Jefferies Healthcare Conference held June 7-9, 2023 in New York City.
- Lumos Pharma management will present and host one-on-one meetings at both conferences.
- BIO International Convention: June 5th – 8th in Boston, MA
Lumos Pharma Presentation – June 6th, 2:45 PM EDT
Jefferies Healthcare Conference: June 7th – 9th in New York, NY
Lumos Pharma Fireside Chat – June 9th, 12:45-1:10 PM EDT
Management will host one-on-one meetings with investors on Friday, June 9th
The webcast for the Jefferies Conference fireside chat will also be found on the Company’s website under Events & Presentations in the Investors & Media section. - Please contact your Jefferies salesperson or Lumos Pharma Investor Relations to schedule one-on-one meetings with the management team during the Jefferies Healthcare Conference or thereafter.